ROSEN, GLOBAL INVESTOR COUNSEL, encourages Abbott Laboratories investors to seek advice … | New

NEW YORK, Sept. 18, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Abbott Laboratories (NYSE:ABT) securities between Feb. 2021 and June 8, 2022, both dates inclusive (the “Class Period”), of the important deadline of October 31, 2022 for lead plaintiff.

SUCH AS: If you purchased Abbott securities during the Class Period, you may be entitled to compensation without payment of disbursements or fees through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Abbott class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=8453 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must move the Court by October 31, 2022. A lead plaintiff is a representative party acting on behalf of other class members to direct litigation.

WHY ROSEN LAW: We encourage investors to select qualified lawyers with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually handle securities class action lawsuits, but are merely middlemen who refer clients or partner with law firms that actually litigate the cases. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) according to the Food and Drug Administration ( “FDA”) of the United States, Abbott had “extremely unsanitary” conditions at its Sturgis, Michigan plant, which produced nearly half of Abbott’s various forms of infant formula under the Similac, Alimentum and EleCare; (2) as a result, Abbott’s infant formula business was in serious jeopardy given gross violations of federal and state health and safety regulations; (3) based on inspections performed by the FDA between 2019 and 2022, Abbott did not establish process controls “designed to ensure that infant formula is not adulterated due to the presence of microorganisms in the formula or in the processing environment” and Abbott also failed to “ensure that all surfaces that came into contact with infant formula were maintained to protect the infant formula from contamination with any source”; (4) unsanitary conditions at the Sturgis facility resulted in the recall of Abbott infant formula and the closure of the Sturgis facility; and (5) therefore, the defendants’ public statements about Abbott’s business, operations and prospects were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit claims investors suffered damages.

To join the Abbott class action, go to https://rosenlegal.com/submit-form/?case_id=8453 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.

No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent group member and do nothing at this point. An investor’s ability to participate in any potential future recovery does not depend on their status as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Lawyer advertisement. Previous results do not guarantee a similar result.

Contact information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, Pennsylvania

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

Copyright 2022 GlobeNewswire, Inc.

Comments are closed.